Profile characteristic | Example descriptions |
---|---|
Document title | A description of the health product profile, including product type, target disease and/or health condition for a target population or geographic location |
Author | The lead organisation that developed and published the health profile. When a profile was published in a journal, the main institutional affiliation of the corresponding author was chosen |
WHO | A check-box to enable quick separation of WHO-authored health product profiles from those authored by others |
Diseases | One or more diseases and/or health conditions (e.g. reproductive health) targeted by the product |
Product type | Short-description of the product type: diagnostic, drug, vaccine, digital health, drug regimen, injectable/implant, not defined. As the directory content grows, these definitions will expand |
Year published | The year the profile document was published |
Status | Active: the profile is still considered relevant Archive: the profile is no longer relevant. In the Health Product Profile Directory, profiles older than 5 years from the current date are considered archive |
Indication | The purpose of the product, e.g. to provide immunisation against a given disease or to identify the presence of a given bacteria in drinking water |
Intended use | Primarily used for diagnostics to separate triage, screening and more precise diagnosis |
Target population | Age group or other specific subpopulation groups |
Sample type and volume | Primarily for diagnostics describing the medium that is tested, e.g. blood, stool, saliva, drinking water |
Use setting | Who would use the product and under what conditions, infrastructure requirements, e.g. trained nurse in a low-resource setting, primary healthcare facility, no cold chain, shelf life |
Performance | Describes for diagnostics: specificity, sensitivity, reproducibility, robustness, time to result, nature of result, qualitative or quantitative |
Efficacy | For drugs and drug regimens: the clinical characteristics, dosing, pharmaco-dynamics, rate of onset of action, interaction with other therapeutics, etc. For vaccines: expected efficacy, duration, reversibility, strain coverage, interaction with other vaccines, etc. |
Safety | For drugs, drug regimens and vaccines: clinical safety and tolerability, safety monitoring requirements, contra-indications and relation to specific population types, e.g. infants, pregnant women, during breast-feeding |
Comments | Additional comments not able to be categorized above |
Document url | Ideally, an archive providing a permanent url where the full document is published openly on line |
Contact email | A contact email for further information |